Projected Income Statement: AMCOR19

Forecast Balance Sheet: AMCOR19

Fiscal Period: June 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 5,439 5,715 6,057 6,111 13,271 13,420 12,730 11,865
Change - 5.07% 5.98% 0.89% 117.17% 1.12% -5.14% -6.79%
Announcement Date 8/17/21 A 8/17/22 A 8/16/23 A 8/15/24 A 8/14/25 A - - -
1USD in Million
Estimates

Cash Flow Forecast: AMCOR19

Fiscal Period: June 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 468 527 526 492 580 877.7 894.7 915.1
Change - 12.61% -0.19% -6.46% 17.89% 51.33% 1.93% 2.28%
Free Cash Flow (FCF) 1 993 999 735 829 810 1,556 1,833 2,066
Change - 0.6% -26.43% 12.79% -2.29% 92.09% 17.8% 12.72%
Announcement Date 8/17/21 A 8/17/22 A 8/16/23 A 8/15/24 A 8/14/25 A - - -
1USD in Million
Estimates

Forecast Financial Ratios: AMCOR19

Fiscal Period: June 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 15.77% 14.56% 13.73% 14.38% 14.56% 15.83% 16.35% 16.94%
EBIT Margin (%) 12.6% 11.7% 10.94% 11.44% 11.48% 12.08% 12.62% 13.17%
EBT Margin (%) 9.28% 7.67% 8.51% 6.65% 4.33% 5.67% 7.75% 8.81%
Net margin (%) 7.3% 5.53% 7.13% 5.35% 3.4% 4.93% 6.31% 6.87%
FCF margin (%) 7.72% 6.87% 5% 6.08% 5.4% 6.73% 7.68% 8.59%
FCF / Net Income (%) 105.75% 124.1% 70.13% 113.56% 158.51% 136.6% 121.71% 125.03%

Profitability

        
ROA 5.58% 7.07% 6.33% 6.05% 4.24% 5.65% 6.32% 6.77%
ROE 24.36% 27.67% 26.49% 25.24% 14.48% 15.77% 16.65% 17.18%

Financial Health

        
Leverage (Debt/EBITDA) 2.68x 2.7x 3x 3.11x 6.07x 3.67x 3.26x 2.91x
Debt / Free cash flow 5.48x 5.72x 8.24x 7.37x 16.38x 8.63x 6.95x 5.74x

Capital Intensity

        
CAPEX / Current Assets (%) 3.64% 3.62% 3.58% 3.61% 3.86% 3.8% 3.75% 3.8%
CAPEX / EBITDA (%) 23.08% 24.89% 26.07% 25.08% 26.53% 23.99% 22.92% 22.44%
CAPEX / FCF (%) 47.13% 52.75% 71.56% 59.35% 71.6% 56.41% 48.81% 44.29%

Items per share

        
Cash flow per share 1 4.695 5.033 4.33 4.6 4.363 4.665 6.58 8.118
Change - 7.2% -13.96% 6.22% -5.15% 6.92% 41.06% 23.36%
Dividend per Share 1 2.35 2.4 2.45 2.5 2.55 2.526 2.543 2.571
Change - 2.13% 2.08% 2.04% 2% -0.95% 0.7% 1.09%
Book Value Per Share 1 15.49 13.73 13.81 15.73 25.44 25.42 26.5 28.25
Change - -11.4% 0.63% 13.88% 61.74% -0.1% 4.27% 6.59%
EPS 1 3.01 2.645 3.525 2.525 1.6 2.446 3.243 3.721
Change - -12.13% 33.27% -28.37% -36.63% 52.86% 32.59% 14.73%
Nbr of stocks (in thousands) 306,405 296,735 287,064 288,869 456,770 462,146 462,146 462,146
Announcement Date 8/17/21 A 8/17/22 A 8/16/23 A 8/15/24 A 8/14/25 A - - -
1USD
Estimates
2026 *2027 *
P/E 17.8x 13.5x
PBR 1.72x 1.65x
EV / Sales 1.45x 1.38x
Yield 5.79% 5.83%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
43.64USD
Average target price
48.21USD
Spread / Average Target
+10.48%

Quarterly revenue - Rate of surprise